Roche Holding AG (RO) CHF1(Bearer)
Share news, reports & tips
26 April 2019 12:15
(Sharecast News) - Roche announced on Friday that it has withdrawn its premerger notification and report form under the US Hart-Scott-Rodino Act, in connection with its pending acquisition of Nasdaq-listed...
23 April 2019 07:27
(Sharecast News) - Roche announced the launch of the new 'VENTANA HER2 Dual ISH DNA Probe Cocktail' assay on Tuesday, for the detection of the HER2 biomarker in breast and gastric cancer.
19 March 2019 11:30
(Sharecast News) - Roche announced on Tuesday that the US Food and Drug Administration (FDA) has approved 'Tecentriq' (atezolizumab), in combination with carboplatin and etoposide chemotherapy, for...
15 March 2019 10:32
(Sharecast News) - Roche announced on Friday that the European Commission has approved 'MabThera' (rituximab) for the treatment of adults with moderate-to-severe pemphigus vulgaris (PV).
25 February 2019 11:27
(Sharecast News) - Swiss drug maker Roche has agreed to buy Philadelphia-based Spark Therapeutics in a $4.3bn cash deal.
19 February 2019 10:03
(Sharecast News) - Roche announced on Tuesday that the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA), and granted 'Priority Review' for polatuzumab...
7 December 2018 10:40
(Sharecast News) - Roche announced on Friday that the US Food and Drug Administration (FDA) approved 'Tecentriq' (atezolizumab) in combination with 'Avastin' (bevacizumab), paclitaxel and...
4 December 2018 14:17
(Sharecast News) - Roche announced new data from the 'Venclexta'/'Venclyxto' (venetoclax) clinical development programme on Tuesday, including longer-term results from the phase III...
3 December 2018 14:16
(Sharecast News) - Roche announced longer-term data from the phase Ib/II GO29365 study on Monday, with positive results from 'polatuzumab vedotin' - an investigational anti-CD79b antibody drug...
1 November 2018 09:28
(Sharecast News) - Roche announced on Thursday that the European Commission has approved 'Venclyxto' (venetoclax) in combination with 'MabThera' (rituximab) for the treatment of adult...
20 August 2018 10:18
(Sharecast News) - Roche announced on Monday that the China National Drug Administration (CNDA) has granted marketing authorisation for 'Alecensa' (alectinib) as a monotherapy treatment for...
3 August 2018 10:17
(Sharecast News) - Roche announced on Friday that the European Medicines Agency has granted 'Priority Medicines' (PRIME) designation for its investigational medicine RG6042 - formerly known as...
Company announcements Announcements
No company announcements about Roche Holding AG CHF1(Bearer) were found.
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see http://www.DigitalLook.com/newsfeedterms for our terms and conditions.
© Digital Look Ltd 1998-2019. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.